IDH3A and central nervous system cancer: Among these, diffuse low-grade glioma (grade II glioma) and intermediated-grade glioma (grade III glioma) make up lower-grade gliomas (LGG) for the similar prognostic effect of isocitrate dehydrogenase (IDH) status in both tumor grades [1,2].